Post-approval studies (Phase 4)Study completedNCT00625339
What this trial is testing
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA
Who this might be right for
Hepatitis B, Chronic
Yonsei University 72